Intrinsic Value
Aeglea BioTherapeutics, Inc. (AGLE)
$12.01
+0.75 (+6.66%)
Enterprise Value | - |
---|---|
Net Debt | -30.23 |
Equity Value | - |
Shares Outstanding | 3.37 |
Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt